Lucid Diagnostics Inc. (LUCD) Dividend History

Company News

• PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024

  PAVmed, a diversified medical technology company, will host a business update conference call and webcast on November 14, 2024, to discuss its third quarter 2024 financial results and provide an overview of its operations and growth strategy.

  Benzinga

  Featured Companies: PAVM
• Wall Street Breakfast: The Week Ahead

  Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

  Seeking Alpha

  Featured Companies: AAL ACB AFRM AMC AMD AMZN ATO AUR AVDX AVGO BBWI BLDE BYND CAH CAR CARR COIN CPNG CSX DAL DDD DIS EFX EPC ETD FLGC FVRR GFF GLBE GTLB HCTI HPQ HUT IHS INKT IPW LMT LOW MARA MCHP MSI NVDA OPEN ORCL PFGC PYPL R RGLD RIOT ROP RTX SBUX SPB SPCE SR SYY TGT TSLA U UBER USFD WEN WMT WSC WYNN XRTX YETI
• Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

  NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the closing on October 18, 2021 of its initial public offering (the “Offering”) of 5,000,000 shares of common stock at a price to the public of $14.00 per share for total gross proceeds of $70,000,000 before deducting underwriting discounts and commissions and estimated offering expenses.

  GlobeNewswire Inc.